Captopril Inhibits Thioacetamide-Induced Chronic Liver Injury Associated with the Suppression of Inflammation/Hypoxia-Inducible Factor 1-alpha / Profibrogenic Axis-Mediated Hepatotoxicity in Rats

DOI :
Tweet about this on TwitterShare on FacebookEmail this to someoneShare on Google+

Ismaeel Bin-Jaliah

Summary

Liver transplantation is the only available method to treat liver failure induced by chronic liver injury. We sought to determine whether the angiotensin-converting enzyme inhibitor, captopril, can inhibit the development of chronic liver injury induced by the hepatotoxic agent thioacetamide (TAA) in association with the suppression of inflammation (hsCRP, TNF-α, and IL-6) / hypoxia- inducible factor 1-alpha (HIF-1α) / profibrosis (TIMP-1, MMP-9, and α-SMA) axis that mediates liver injury. Therefore, the model group of rats was injected for eight weeks with 200 mg/kg TAA starting at week two. The protective group was pretreated with 150 mg/ kg captopril daily for two weeks prior to TAA injections and continued receiving both capropril and TAA agents until being humanely scrificed at week 10. We observed a substantial damage to liver tissue in the model group as demonstrated by a significant (p<0.0001) increase in blood and hepatic tissue levels of high sensitivity C-reactive protein (hsCRP), tumor necrosis factor-a (TNF-α), interleukin- 6 (L-6), HIF-1α, tissue inhibitor of metalloproteinases-1 (TIMP-1), matrix metalloproteinase-9 (MMP-9), alpha-smooth muscle actin (α-SMA), alanine aminotransferase (ALT), and aspartate aminotransferase (AST). All these parameters were significantly (p<0.0244) protected by captopril. Also, a significant (p<0.0001) positive correlation was observed between a-SMA (profibrosis) and the serum and tissue levels of hsCRP, TNF-α, HIF-1α, TIMP-1, MMP-9, and ALT. Thus, these findings suggest that the induction of chronic liver injury by the hepatotoxic compound, TAA is associated with the upregulation of inflammation/HIF-1α/profibrosis, with captopril exhibiting beneficial hepatic pleotropic effects.

KEY WORDS: Liver injury; Thioacetamide; Inflammation; HIF-1α; Profibrosis; Rat; Model.

How to cite this article

BIN-JALIAH,I. Captoprilinhibitsthioacetamide-inducedchronicliverinjuryassociatedwiththesuppressionofinflammation/hypoxia- inducible factor 1-alpha / profibrogenic axis-mediated hepatotoxicity in rats. Int. J. Morphol., 41(2):362-367, 2023.